All Articles
Browse every published article, from the latest research to earlier analysis. Use the page numbers below to explore the complete archive.
Serum/Plasma Ethanol vs Whole-Blood BAC: Forensic Conversion
Why hospital serum/plasma ethanol runs higher than whole-blood BAC, how conversion ratios vary, and what forensic interpretation should account for.
Retrograde BAC Extrapolation: Assumptions, Absorption, and Uncertainty
Retrograde BAC extrapolation can be useful only when its absorption, elimination, timing, specimen, and uncertainty assumptions are justified case by case.
Postmortem Drug Concentrations: Why Reference Ranges Overlap
Why therapeutic, toxic and fatal postmortem drug ranges overlap—and how specimen site, redistribution, tolerance, and co-intoxicants change interpretation.
Bromazolam in Forensic Toxicology: Blood, Urine, Postmortem, and DUID Interpretation
Bromazolam is an emerging designer benzodiazepine increasingly encountered in forensic casework. This guide explains analytical detection, blood and urine interpretation, postmortem redistribution, polydrug findings, and the limits of concentration-based conclusions.
Nitazene Metabolites in Forensic Toxicology: Urine, Blood, and LC-MS/MS Interpretation
Nitazene metabolite testing can materially improve detection when parent drug concentrations are low or absent. A forensic guide to urine and blood biomarkers, LC-MS/MS and LC-HRMS interpretation, hydrolysis, postmortem casework, and the limits of metabolite-based timing conclusions.
7-Hydroxymitragynine (7-OH) in Forensic Toxicology: Testing and Interpretation
Forensic interpretation of 7-hydroxymitragynine (7-OH): LC-MS/MS testing, blood and urine findings, product composition, metabolism, and postmortem limits.
Xylazine in Forensic Toxicology: Detection, Metabolites, and Interpretation
A technical guide to xylazine testing in forensic toxicology, including LC-MS/MS detection, blood and urine interpretation, metabolites, postmortem limitations, fentanyl co-exposure, and records to review.
EtG, EtS, and PEth in Forensic Toxicology: Alcohol Biomarkers and Interpretation
EtG, EtS, and PEth answer different alcohol-exposure questions. This forensic toxicology guide explains specimen choice, detection windows, analytical methods, interpretive limits, postmortem issues, and why no single biomarker proves an exact drinking time or dose.
When an Ecstasy or Molly Result Is Not MDMA: Reagent Tests, Adulterants, and Confirmatory Analysis
Why street names and color reagents cannot establish MDMA identity, and what compound-specific confirmatory testing should document.
Cocaethylene in Forensic Toxicology: Cocaine, Ethanol and Interpretation
Technical guide to cocaethylene formation when cocaine and ethanol overlap, including blood and postmortem interpretation, metabolism, stability, analytical testing, cardiotoxicity evidence, and limits of timing or impairment opinions.
1,1-Difluoroethane (DFE) Forensic Toxicology
Forensic guide to 1,1-difluoroethane (DFE): blood detection, headspace GC testing, volatile loss, postmortem specimens, impairment, and interpretation limits.
Residual THC in Frequent Cannabis Users: What Blood, Urine, and Oral Fluid Can—and Cannot Date
Controlled-abstinence studies show that frequent cannabis users can retain measurable cannabinoids for days. Learn why detection, recent use, and impairment are separate questions.
Comparing Two Toxicology Reports: A Specimen and Method Worksheet
Compare specimen, collection time, analyte, method, units, and reporting thresholds before treating two toxicology results as agreement or disagreement.
A New Nitazene Plasma Method: Reading Beyond the Detection Limit
Interpret a 2026 micro-QuEChERS LC–MS/MS method through its matrix, quantitative range, validation limits, and casework application.
Nitazene Test Strips: Analogue Coverage and Caffeine Interference
A laboratory evaluation shows why nitazene strip results depend on the analogue, concentration, and mixture rather than the class name alone.
Mitragynine and Its Diastereomers: Why Accurate Mass Is Not Enough
A urine study demonstrates how co-eluting kratom alkaloids can affect mitragynine identification and threshold-based reporting.
Medetomidine in Urine: Metabolites, Hydrolysis, and Negative Results
How metabolite selection and enzymatic pretreatment affect medetomidine exposure detection, with limits on interpretation of urine concentrations.
7-Hydroxymitragynine Stability: What a Plasma Experiment Can Establish
Distinguish experimental conversion of 7-OH in human plasma from validated specimen stability, in-vivo kinetics, and product attribution.
Nitazenes in Dried Blood Spots: Storage Findings Need Compound-Specific Interpretation
A four-nitazene stability study illustrates why storage conclusions depend on concentration, temperature, matrix, and the measured endpoint.
Postmortem Methamphetamine Redistribution: Why Sampling Site Changes the Result
Postmortem methamphetamine can differ across heart, peripheral blood, vitreous, and tissues. Learn why published ratios are evidence—not universal correction factors.
Toxicology Laboratory Records: Evidence Review Checklist
A checklist of toxicology laboratory records for evidence review, covering specimen handling, methods, validation, quality controls, and underlying data.
What a Fentanyl Test Strip Can and Cannot Establish
A published five-lot study shows why fentanyl test-strip results depend on lot, analog, interference, dilution, and the limits of a negative response.
What a Blue Scott Cocaine Test Really Shows
A blue Scott-test response is presumptive. Published cobalt-thiocyanate research explains lidocaine interference, reaction chemistry, and why confirmation records matter.
When Newborn THC Urine Screens Meet Specimen Contamination
A published study found assay-dependent baby-wash interference in newborn cannabinoid urine screening, making collection and confirmation records essential.
When Matching LC-MS/MS Transitions Do Not Prove THCCOOH Identity
An authentic-serum interference shared monitored THCCOOH transitions, showing why chromatographic separation and revalidation matter.
Postmortem Blood Sampling Sites: Interpretation Guide
Compare central and peripheral postmortem blood, collection artifacts, redistribution, and the records needed to interpret toxicology results.
Postmortem Ethanol: Formation, Preservation, Interpretation
Postmortem ethanol may reflect drinking, microbial formation, or both. Learn how matrix, collection, preservation, and biomarkers shape interpretation.
What a Negative Urine Immunoassay Does Not Exclude
A negative urine immunoassay does not exclude every drug or exposure. Assay targets, cutoffs, timing, dilution, and device effects shape the result.
Methamphetamine Blood Levels and Driving Impairment
Review what methamphetamine blood results can establish, why studies disagree about concentration and impairment, and which records support interpretation.
Methamphetamine Driving Studies: Concentration, Fatigue & SFSTs
Technical review of controlled and forensic methamphetamine driving studies: concentration-effect findings, simulator performance, fatigue, SFSTs, and limits of applying group data to individual cases.